Eberhard Riedel

755 total citations
62 papers, 568 citations indexed

About

Eberhard Riedel is a scholar working on Nephrology, Hematology and Clinical Biochemistry. According to data from OpenAlex, Eberhard Riedel has authored 62 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 13 papers in Hematology and 7 papers in Clinical Biochemistry. Recurrent topics in Eberhard Riedel's work include Dialysis and Renal Disease Management (13 papers), Erythropoietin and Anemia Treatment (13 papers) and Metabolism and Genetic Disorders (7 papers). Eberhard Riedel is often cited by papers focused on Dialysis and Renal Disease Management (13 papers), Erythropoietin and Anemia Treatment (13 papers) and Metabolism and Genetic Disorders (7 papers). Eberhard Riedel collaborates with scholars based in Germany, United States and United Kingdom. Eberhard Riedel's co-authors include Hannelore Hampl, H. Hampl, Rudolf Hänsel, Tilman Grune, Olaf Sommerburg, Wolfgang Pommer, Werner Beck, Reinhold Deppisch, P. Neuhaus and Christian Rosenberger and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and Journal of Lipid Research.

In The Last Decade

Eberhard Riedel

58 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eberhard Riedel Germany 15 133 99 77 71 68 62 568
Tahereh Safari Iran 18 92 0.7× 30 0.3× 79 1.0× 32 0.5× 30 0.4× 43 771
Sedigheh Shams Iran 13 52 0.4× 38 0.4× 156 2.0× 63 0.9× 49 0.7× 39 554
Fen Jiang China 15 39 0.3× 14 0.1× 131 1.7× 76 1.1× 114 1.7× 58 847
Bahadır Öztürk Türkiye 14 37 0.3× 12 0.1× 100 1.3× 32 0.5× 50 0.7× 54 502
Susan Tucker United Kingdom 9 72 0.5× 12 0.1× 90 1.2× 98 1.4× 38 0.6× 26 514
Ahmed Al-Shukaili Oman 11 28 0.2× 20 0.2× 115 1.5× 86 1.2× 29 0.4× 21 562
Xiaofan Liu China 12 17 0.1× 162 1.6× 178 2.3× 30 0.4× 40 0.6× 66 1.0k
Eli̇f Oğuz Türkiye 14 20 0.2× 19 0.2× 114 1.5× 61 0.9× 75 1.1× 50 545
Zora Krivošíková Slovakia 15 113 0.8× 13 0.1× 96 1.2× 79 1.1× 47 0.7× 51 610
Ahmet Musmul Türkiye 12 26 0.2× 14 0.1× 79 1.0× 37 0.5× 50 0.7× 58 469

Countries citing papers authored by Eberhard Riedel

Since Specialization
Citations

This map shows the geographic impact of Eberhard Riedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Riedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Riedel more than expected).

Fields of papers citing papers by Eberhard Riedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Riedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Riedel. The network helps show where Eberhard Riedel may publish in the future.

Co-authorship network of co-authors of Eberhard Riedel

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Riedel. A scholar is included among the top collaborators of Eberhard Riedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Riedel. Eberhard Riedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedel, Eberhard, et al.. (2015). Severity of Anaemia Influences Pattern of Amino Acids and a-Keto Acids in Haemodialysis Patients. Contributions to nephrology. 98. 98–104.
2.
Hampl, Hannelore & Eberhard Riedel. (2009). Cardiac Disease in the Dialysis Patient: Good, Better, Best Clinical Practice. Blood Purification. 27(1). 99–113. 6 indexed citations
3.
Hampl, H., et al.. (2005). Proven Strategies to Reduce Cardiovascular Mortality in Hemodialysis Patients. Blood Purification. 24(1). 100–106. 3 indexed citations
4.
Hampl, Hannelore, et al.. (2005). Effects of Optimized Heart Failure Therapy and Anemia Correction with Epoetin β on Left Ventricular Mass in Hemodialysis Patients. American Journal of Nephrology. 25(3). 211–220. 32 indexed citations
5.
Hampl, Hannelore, et al.. (2005). Optimized Heart Failure Therapy and Complete Anemia Correction on Left-Ventricular Hypertrophy in Nondiabetic and Diabetic Patients Undergoing Hemodialysis. Kidney & Blood Pressure Research. 28(5-6). 353–362. 5 indexed citations
6.
Riedel, Eberhard, et al.. (2001). Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes. Kidney International. 59. S19–S24. 28 indexed citations
7.
Luhm, Jürgen, Andra B. Schromm, Ulrich Seydel, et al.. (1998). Hypothermia enhances the biological activity of lipopolysaccharide by altering its fluidity state. European Journal of Biochemistry. 256(2). 325–333. 25 indexed citations
8.
Mankertz, Joachim, et al.. (1997). Low Density Lipoproteins as Drug Carriers in the Therapy of Macrophage-Associated Diseases. Biochemical and Biophysical Research Communications. 240(1). 112–115. 9 indexed citations
9.
Zeilinger, Katrin, et al.. (1997). Effect of energy substrates on the preservation outcome of hepatocytes and sinusoidal endothelial cells in an Experimental Hypoxia/Reoxygenation Model. Transplantation Proceedings. 29(1-2). 403–405. 6 indexed citations
10.
Riedel, Eberhard, et al.. (1996). α-Ketoglutarate Application in Hemodialysis Patients Improves Amino Acid Metabolism. Nephron. 74(2). 261–265. 35 indexed citations
11.
Mankertz, Joachim, Eckart Matthes, K. Rokos, et al.. (1996). Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1317(3). 233–237. 8 indexed citations
12.
13.
Riedel, Eberhard, et al.. (1992). Essential branched-chain amino acids and α-ketoanalogues in haemodialysis patients. Nephrology Dialysis Transplantation. 7(2). 117–120. 13 indexed citations
14.
Musch, E., Jasna Peter‐Katalinić, Heinz Egge, et al.. (1992). Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro. Cancer Chemotherapy and Pharmacology. 29(4). 297–304. 1 indexed citations
15.
Siems, Werner, et al.. (1992). Changed Purine Nucleotide Concentrations and Enzyme Activities in Erythrocytes of Haemodialysis Patients Undergoing Erythropoietin Therapy. Clinical Chemistry and Laboratory Medicine (CCLM). 30(8). 455–60. 4 indexed citations
16.
Loos, U., et al.. (1991). Comparative Pharmacokinetics of Chlorambucil and Prednimustine after Oral Administration. Oncology. 48(4). 334–342. 2 indexed citations
17.
Baeyer, Hans von, et al.. (1991). Preparation of Nucleoside-LDL-Conjugates for the Study of Cell-Selective Internalization: Stability Characteristics and Receptor Affinity. Clinical Chemistry and Laboratory Medicine (CCLM). 29(10). 665–74. 5 indexed citations
18.
Hampl, Hannelore, et al.. (1990). Red Blood Cell Density Distribution in Uremic Patients on Acetate and Bicarbonate Hemodialysis. Blood Purification. 8(5). 260–267. 4 indexed citations
19.
Riedel, Eberhard, et al.. (1989). Changes in the Concentrations of Hydroxyproline, Glycine and Serine in the Plasma of Haemodialysis Patients Undergoing, Erythropoietin Therapy. Clinical Chemistry and Laboratory Medicine (CCLM). 27(11). 851–6. 2 indexed citations
20.
Riedel, Eberhard, et al.. (1983). Experimentelle Untersuchungen zur Frage der Arterialisierung der Herzvenen in der Anfangsphase der Myokardischämie beim Minischwein. European surgery. Supplement/European surgery. 15(2). 25–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tahereh Safari Breakdown of academic impact, for papers by Sedigheh Shams Breakdown of academic impact, for papers by Fen Jiang Breakdown of academic impact, for papers by Bahadır Öztürk Breakdown of academic impact, for papers by Susan Tucker Breakdown of academic impact, for papers by Ahmed Al-Shukaili Breakdown of academic impact, for papers by Xiaofan Liu Breakdown of academic impact, for papers by Eli̇f Oğuz Breakdown of academic impact, for papers by Zora Krivošíková Breakdown of academic impact, for papers by Ahmet Musmul
Rankless by CCL
2026